Study to Evaluate the Effect on Parameters of Systemic Inflammation and Disease Outcomes and Safety of RPH-104 in Subjects With Acute ST-elevation Myocardial Infarction
Condition: Acute ST Segment Elevation Myocardial Infarction Interventions: Biological: RPH-104 80 mg; Drug: Placebo Sponsors: R-Pharm Overseas, Inc.; Cromos Pharma, LLC; DM 365, LLC; Keystat, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials